UBS Maintains Buy on Viatris, Raises Price Target to $26
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
UBS analyst Ashwani Verma maintains Viatris (NASDAQ:VTRS) with a Buy and raises the price target from $23 to $26.
UBS analyst Ashwani Verma maintains Viatris (NASDAQ:VTRS) with a Buy and raises the price target from $23 to $26.